Some of today’s large language models may be more effective communicators than providers when it comes to explaining interventional radiology procedures.
The U.S. Food and Drug Administration highlighted concerns about "data drift," which can potentially lead to performance degradation, bias or reduced reliability.
This uptick was attributed to more scans being administered per ED visit, rather than a rise in overall patient volumes, an analysis of Medicare data found.
Julianna Czum, MD, of Johns Hopkins Medicine, made her case in the American Journal of Roentgenology on Wednesday, with 2 Utah rads issuing a rebuttal.
Experts see particular benefit in “situations with high case volumes, which often lead to long work lists and reading delays," according to research published in Academic Radiology.
An updated version of Heartflow's Plaque Analysis platform has gained FDA clearance. In addition, the company announced that Cigna will cover the platform going forward.
Several groups collaborated on the document, which is designed to help clinicians provide high-quality, consistent care when using flurpiridaz during cardiac PET imaging exams.
